BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 11369653)

  • 21. Acute myeloid leukemia M4 with bone marrow eosinophilia (M4Eo) and inv(16)(p13q22) exhibits a specific immunophenotype with CD2 expression.
    Adriaansen HJ; te Boekhorst PA; Hagemeijer AM; van der Schoot CE; Delwel HR; van Dongen JJ
    Blood; 1993 Jun; 81(11):3043-51. PubMed ID: 8098967
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced myeloid specificity of CD117 compared with CD13 and CD33.
    Nomdedéu JF; Mateu R; Altès A; Llorente A; Rio C; Estivill C; López O; Ubeda J; Rubiol E
    Leuk Res; 1999 Apr; 23(4):341-7. PubMed ID: 10229319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence, sensitivity, and specificity of leukemia-associated phenotypes in acute myeloid leukemia using specific five-color multiparameter flow cytometry.
    Al-Mawali A; Gillis D; Hissaria P; Lewis I
    Am J Clin Pathol; 2008 Jun; 129(6):934-45. PubMed ID: 18480011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The applicability of multiparameter flow cytometry for the detection of minimal residual disease using different-from-normal panels to predict relapse in patients with acute myeloid leukemia after allogeneic transplantation.
    Wang Z; Guo M; Zhang Y; Xu S; Cheng H; Wu J; Zhang W; Hu X; Yang J; Wang J; Tang G
    Int J Lab Hematol; 2019 Oct; 41(5):607-614. PubMed ID: 31162830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Distribution of antigenic aberration in the bone marrow of acute leukemia in complete remission].
    Shin S; Kahng J; Kim M; Lim J; Kim Y; Han K
    Korean J Lab Med; 2008 Feb; 28(1):1-7. PubMed ID: 18309249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic value of immunophenotyping in elderly patients with acute myeloid leukemia: a single-institution experience.
    Plesa C; Chelghoum Y; Plesa A; Elhamri M; Tigaud I; Michallet M; Dumontet C; Thomas X
    Cancer; 2008 Feb; 112(3):572-80. PubMed ID: 18085638
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of the CD33-related Siglec receptor, Siglec-5 (CD170), as a useful marker in both normal myelopoiesis and acute myeloid leukaemias.
    Virgo P; Denning-Kendall PA; Erickson-Miller CL; Singha S; Evely R; Hows JM; Freeman SD
    Br J Haematol; 2003 Nov; 123(3):420-30. PubMed ID: 14617000
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunophenotype distinction between acute promyelocytic leukaemia and CD15- CD34- HLA-DR- acute myeloid leukaemia with nucleophosmin mutations.
    Ferrari A; Bussaglia E; Úbeda J; Facchini L; Aventin A; Sierra J; Nomdedéu JF
    Hematol Oncol; 2012 Sep; 30(3):109-14. PubMed ID: 21812014
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
    Pituch-Noworolska A
    Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The immunophenotypic and clinical characteristics of NPM1 mutated acute myeloid leukemia patients].
    Liu YR; Chang Y; Ruan GR; Qin YZ; Lai YY; Shi HX; Wang YZ; Li LD; Jiang B; Li JL
    Zhonghua Xue Ye Xue Za Zhi; 2013 Feb; 34(2):98-103. PubMed ID: 23611213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Myeloid antigen, CD13, CD14, and/or CD33 expression is restricted to certain lymphoid neoplasms.
    Nakase K; Kita K; Shiku H; Tanaka I; Nasu K; Dohy H; Kyo T; Tsutani H; Kamada N
    Am J Clin Pathol; 1996 Jun; 105(6):761-8. PubMed ID: 8659452
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The use of monoclonal antibodies for immunologic typing and prognosis prediction in acute non-lymphoblastic leukemia].
    Chen GB; Tang MH; Yang TY
    Zhonghua Nei Ke Za Zhi; 1993 Jun; 32(6):405-8. PubMed ID: 7903627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surface markers in adult acute myeloblastic leukemia: correlation of CD19+, CD34+ and CD14+/DR--phenotypes with shorter survival. Groupe d'Etude Immunologique des Leucémies (GEIL).
    Solary E; Casasnovas RO; Campos L; Béné MC; Faure G; Maingon P; Falkenrodt A; Lenormand B; Genetet N
    Leukemia; 1992 May; 6(5):393-9. PubMed ID: 1375696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute myeloid leukemia M2 and t(8;21)(q22;q22) with an unusual phenotype: myeloperoxidase (+), CD13 (-), CD14 (-), and CD33(-).
    García Vela JA; Martin M; Delgado I; García Alonso L; Monteserin MC; Benito L; Somolinos N; Oña F
    Ann Hematol; 1999 May; 78(5):237-40. PubMed ID: 10391105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression of Th17 and IL-23 in Peripheral Blood and Their Relationship with Immunophenotype in Patients with Acute Myeloid Leukemia].
    Peng ZY; Yang CX; San JH; Li QQ; Zhang MM; Shi B
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Aug; 30(4):1056-1062. PubMed ID: 35981362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of immunophenotypic characteristics of blast cells in acute myeloid leukemia.
    Lanza F; Rigolin GM; Moretti S; Latorraca A; Castoldi G
    Leuk Lymphoma; 1994; 13 Suppl 1():81-5. PubMed ID: 7521238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute myeloid leukemia with 11q23 translocations: myelomonocytic immunophenotype by multiparameter flow cytometry.
    Baer MR; Stewart CC; Lawrence D; Arthur DC; Mrózek K; Strout MP; Davey FR; Schiffer CA; Bloomfield CD
    Leukemia; 1998 Mar; 12(3):317-25. PubMed ID: 9529125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
    Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M
    Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of aberrant phenotypes in acute myeloblastic leukemia.
    Macedo A; Orfão A; Vidriales MB; López-Berges MC; Valverde B; González M; Caballero MD; Ramos F; Martínez M; Fernández-Calvo J
    Ann Hematol; 1995 Apr; 70(4):189-94. PubMed ID: 7748963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pattern associated leukemia immunophenotypes and measurable disease detection in acute myeloid leukemia or myelodysplastic syndrome with mutated NPM1.
    Zhou Y; Moon A; Hoyle E; Fromm JR; Chen X; Soma L; Salipante SJ; Wood BL; Wu D
    Cytometry B Clin Cytom; 2019 Jan; 96(1):67-72. PubMed ID: 30417521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.